Panel Discussion: Ophthalmic Gene Therapy Patient Perspective
Time: 4:05 pm
day: Day One
- Do patients feel they know what treatments are available to them?
- Is there trial data available to patients so they can decide if they want to participate?
- How can an open line of communication be developed between patients and the industry?